Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Polycystic Ovary Syndrome (PCOS) often leads to severe acne, and lifestyle changes and hormonal treatments can help manage it.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

PCOS is a major cause of infertility in women of childbearing age.

Acupuncture may improve reproductive and metabolic functions in PCOS without negative side effects, but more research is needed to confirm its effectiveness.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

Metformin helps reduce PCOS-related infertility by improving insulin sensitivity and inducing ovulation.

Adult acne is more common in women, often linked to hormones, and can be harder to treat.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.